The new facility will enable production of 25 million more patient doses per year of contrast media by the end of 2027.
Moranne et al. report that, with adequate hydration, stable PD patients do not exhibit accelerated decline following iodinated contrast medium administration (ICMA). In a prospective, single ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback